Tarsus Pharmaceuticals Inc (TARS)
CapEx to Revenue
2.34%
Quarterly · Period ending:
TARS CapEx to Revenue
Latest reported2.34%period ending
Latest reported2.34%period ending
TARS Quarterly CapEx/Revenue (0.00% → 2.34%)
Latest values, visible window
High-resolution chart · PNG
TARS capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 2.3397% | |
| 3.5902% | |
| 4.1921% | |
| 1.6091% | |
| 0.9751% | |
| 0.7532% | |
| 7.6376% | |
| 0.5861% | |
| 2.5458% | |
| 0.6301% | |
| 0% | |
| 233.8322% | |
| 0% | |
| 13.6% | |
| 1.27% | |
| 0% | |
| 0.7986% | |
| 29.8701% | |
| 81.0651% | |
| 9.7581% | |
| 0.0727% | |
| 0.5235% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |